Marcy Bolster to Pulmonary Fibrosis
This is a "connection" page, showing publications Marcy Bolster has written about Pulmonary Fibrosis.
Connection Strength
0.297
-
Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum. 1997 Apr; 40(4):743-51.
Score: 0.122
-
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med. 2007 Nov 15; 176(10):1026-34.
Score: 0.063
-
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis. 2007 Dec; 66(12):1641-7.
Score: 0.061
-
Lung disease in systemic sclerosis (scleroderma). Baillieres Clin Rheumatol. 1993 Feb; 7(1):79-97.
Score: 0.023
-
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry. Ann Rheum Dis. 2012 Aug; 71(8):1335-42.
Score: 0.021
-
Scleroderma and related conditions. Med Clin North Am. 1997 Jan; 81(1):129-49.
Score: 0.007